REQUEST A DEMO
Total
USD $0.00
Search more companies

Viapharma S.R.O. (Czech Republic)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Viapharma S.R.O. Profile Updated: November 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Viapharma S.R.O. is a company located in Prague, Czech Republic. It has been operating under its current name since October 2013. Previously known as Gehe Pharma, the company underwent a name change due to a change in ownership. It is now owned by Penta Investments, who acquired the company from the Czech division of the German pharmaceutical company Celesio. Viapharma's main customer is Dr. Max pharmacies, but they also supply the independent market, as well as hospitals, reproductive clinics, hospices, and senior homes. The company is one of the leading distributors of pharmaceutical products in the Czech Republic. They operate three modern distribution centers in Pavlov, Kladno, Brno, and Ostrava. These centers are equipped with state-of-the-art technology to provide comprehensive supply services to pharmacies and hospitals. Viapharma aims to become the preferred partner in the hospital environment through their project "ViaPharma - Partner of Your Hospital." They guarantee the timely delivery of high-quality products to their customers.

Headquarters
Na Florenci 2116/15
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Viapharma S.R.O. report to view the information.

Website: http://viapharma.cz/

Basic Information
Total Employees:
Purchase the Viapharma S.R.O. report to view the information.
Outstanding Shares:
Purchase the Viapharma S.R.O. report to view the information.
Registered Capital:
Purchase the Viapharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Viapharma S.R.O. report to view the information.
Incorporation Date:
February 21, 1991
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Pharmdata, S.R.O.
33.33%
Company Performance
Financial values in the chart are available after Viapharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
2.88%
Total operating revenue
2.96%
Operating profit (EBIT)
18.28%
EBITDA
24.42%
Net Profit (Loss) for the Period
36.89%
Total assets
5.91%
Total equity
30.77%
Operating Profit Margin (ROS)
0.44%
Net Profit Margin
0.64%
Return on Equity (ROE)
1.05%
Debt to Equity Ratio
-65.89%
Quick Ratio
0.09%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?